Leef Brands LEEEF

OTC LEEEF
$0.20 +0.00 (+1.54%)
At close: Aug 19, 2026 · 3:36 PM UTC
Financial Ratios
Market Cap58.55 Mn
P/E-12.12
P/S1.69
Div. Yield0.00
ROIC (Qtr)-0.35
Total Debt (Qtr)10.58 Mn
Revenue Growth (1y) (Qtr)-16.30
Add ratio to table…

About

Leef Brands, Inc. is a vertically integrated cannabis extraction and manufacturing operator based in California. The company engages in the cultivation of cannabis, extraction of cannabinoids using ethanol, hydrocarbon and solventless methods, and production of bulk concentrates such as distillate oil, live resin and rosin. It supplies these products to other cannabis brands and retailers in the regulated markets of California and New York while also maintaining a CBD…

Read more ↓
Sector: Consumer Staples Sector rationale The company's primary business is the cultivation, extraction, and manufacturing of cannabis and CBD products, which falls under the 'Cannabis' industry within Consumer Staples. Its revenue is generated from selling bulk concentrates to other cannabis brands and selling its own CBD wellness line to consumers and retailers. Industries: Cannabis Consumer Staples Primary Leef Brands is a vertically integrated cannabis operator that engages in the cultivation of cannabis and the production of bulk concentrates like distillate oil, live resin, and rosin. It generates revenue from selling these cannabis products to licensed brands and retailers in California and New York. Personal Care Products Consumer Staples Secondary The company operates the LEEF Organics segment, which markets a CBD wellness line including products such as the Recover CBD Roll on and Chill CBD Balm sold through online channels and spas. Classified using BQ-MICS CIK: 0001711141

Subsegments Breakdown of Revenue (2025)

Subsegments Breakdown of Revenue (2025)

Peer Comparison

Companies in the Drug Manufacturers - Specialty & Generic
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 HLN Haleon plc 86.50 Bn80.681.67-5.81 Bn
2 TEVA Teva Pharmaceutical Industries Ltd 42.71 Bn61.362.4716.59 Bn
3 ZTS Zoetis Inc. 30.86 Bn11.803.249.05 Bn
4 TAK Takeda Pharmaceutical Co Ltd 28.50 Bn49.630.6131.47 Bn
5 UTHR UNITED THERAPEUTICS Corp 22.06 Bn16.836.99-
6 VTRS Viatris Inc 18.84 Bn-45.871.2813.35 Bn
7 NBIX Neurocrine Biosciences Inc 15.55 Bn22.034.61-
8 VREOF Vireo Growth Inc. 11.86 Bn-238.0033.850.20 Bn